Desferrioxamine, ocular toxicity, and trace metals. 1983

P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras

UI MeSH Term Description Entries
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014131 Trace Elements A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Biometal,Biometals,Trace Element,Trace Mineral,Trace Minerals,Element, Trace,Elements, Trace,Mineral, Trace,Minerals, Trace
D014786 Vision Disorders Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132). Hemeralopia,Macropsia,Micropsia,Day Blindness,Metamorphopsia,Vision Disability,Visual Disorders,Visual Impairment,Blindness, Day,Disabilities, Vision,Disability, Vision,Disorder, Visual,Disorders, Visual,Hemeralopias,Impairment, Visual,Impairments, Visual,Macropsias,Metamorphopsias,Micropsias,Vision Disabilities,Vision Disorder,Visual Disorder,Visual Impairments

Related Publications

P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
April 1985, Lancet (London, England),
P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
July 1985, The Quarterly journal of medicine,
P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
March 1988, Archives of disease in childhood,
P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
February 1968, Archives of environmental health,
P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
July 2012, Indian journal of ophthalmology,
P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
July 1983, Lancet (London, England),
P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
January 1962, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
January 1990, Nephron,
P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
January 1974, The New England journal of medicine,
P Simon, and K S Ang, and A Meyrier, and P Allain, and Y Mauras
May 1986, The British journal of ophthalmology,
Copied contents to your clipboard!